Articles tagged with Neuropharmacology
Researchers have discovered a protein called "shank" that acts as a biomarker for modifiable memories. This discovery may lead to the development of new treatments for Post-Traumatic Stress Disorder (PTSD) by identifying factors that make memories susceptible to change.
Stephen Waxman, MD, PhD, of Yale University, received the Julius Axelrod Prize for his distinguished contributions to neuropharmacology and exemplary mentoring efforts. He is being recognized for his work on ion channels in nervous system disorders, including spinal cord injury and multiple sclerosis.
Pietro De Camilli is awarded the Julius Axelrod Prize for his outstanding achievements in neuropharmacology and commitment to mentoring young scientists. His work has shed light on neurotransmitter release and membrane trafficking, with implications for understanding diseases of the nervous system.